Merck & Co. Inc. vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Merck & Co. Inc. (MRK) carries a "Neutral" signal with -2.2% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Healthcare sector.
| Metric | Merck & Co. Inc. (MRK) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $16.3B | $14.5B |
| Revenue Growth | -2.2%* | -18.4% |
| Latest EPS | $-1.72 | $0.47* |
| EPS Growth | -238.7% | -39.7%* |
| Sector | Healthcare | Healthcare |
| Quarters Tracked | 8 | 8 |
Merck & Co. Inc. (MRK) carries a "Neutral" signal with -2.2% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Healthcare sector.